| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used by operating activities | -1,989 | -1,376 |
| Payments received on notes receivable | 2 | 1 |
| Net cash provided by investing activities | 2 | 1 |
| Borrowings on note payable, related party | - | 0 |
| Net cash provided by financing activities | - | 0 |
| Net increase (decrease) in cash | -1,987 | -1,375 |
| Cash and cash equivalents at beginning of period | 1,999 | - |
| Cash and cash equivalents at end of period | 12 | - |
IMPACT BIOMEDICAL INC. (IBO)
IMPACT BIOMEDICAL INC. (IBO)